Wade Thorstad

Medicine & Life Sciences

1. Squamous Cell Carcinoma 100%
2. Radiotherapy 85%
3. Oropharyngeal Neoplasms 59%
4. Survival 57%
5. Squamous Cell Carcinoma of Head and Neck 52%
6. Neck 42%
7. Head and Neck Neoplasms 38%
8. Neoplasms 37%
9. Radiation 32%
10. Recurrence 30%
11. Head 25%
12. 130-nm albumin-bound paclitaxel 21%
13. Induction Chemotherapy 21%
14. Cisplatin 21%
15. Radiation Oncology 20%
16. Cetuximab 20%
17. Therapeutics 17%
18. Tumor Burden 17%
19. Disease-Free Survival 17%
20. Neoplasm Metastasis 16%
21. Carcinoma 15%
22. Merkel Cell Carcinoma 15%
23. Oropharynx 14%
24. Papillomaviridae 13%
25. Confidence Intervals 13%
26. Extranodal Extension 13%
27. Neck Dissection 12%
28. MicroRNAs 12%
29. Lymph Nodes 11%
30. Datasets 11%
31. Intensity-Modulated Radiotherapy 10%
32. Nomograms 9%
33. TP protocol 9%
34. Biomarkers 9%
35. Progression-Free Survival 8%
36. Palatine Tonsil 8%
37. In Situ Hybridization 8%
38. Fluorouracil 8%
39. Tomography 8%
40. Smoking 8%
41. Larynx 8%
42. Artifacts 8%
43. Amifostine 7%
44. Xerostomia 7%
45. Skin Neoplasms 7%
46. pembrolizumab 7%
47. Salivary Glands 7%
48. Iodine-131 7%
49. Non-Small Cell Lung Carcinoma 7%
50. Drug Therapy 7%